...Type: Venture financing Raised: Not disclosed Investors: Medwell Capital Corp.; iNovia Capital; MSBi Valorisation Inc.; VIMAC...

...Venture financing Raised: $18.6 million Investors: Kleiner Perkins Caufield & Byers; TVM Capital; Quaker BioVentures; VIMAC...

...series A round led by Kleiner Perkins Caufield & Byers. TVM Capital; Quaker BioVentures; and VIMAC...

...University Corporate partners: None Number of employees: 7 Funds raised: Less than $4 million Investors: VIMAC...

...Mimetogen Pharmaceuticals Inc. , Montreal, Quebec Business: Cancer Appointed: Dana Ono, a managing director at Vimac...

...in 2006 (see B21). The round was co-led by the Aurora Funds; Quaker BioVentures; and VIMAC...

...$10 million in a series A round co-led by the Aurora Funds; Quaker BioVentures; and VIMAC...

...week, including a $0.46 gain to $49.92 on 6.7 million shares on Friday. Fund watch VIMAC...
...for its early stage life sciences fund, Vimac Milestone Medica Fund. Special limited partners include VIMAC...
...and in-licensing company BTG plc (LSE:BTG). The Solidarity Fund QFL also participated as an investor. VIMAC...

...company about two to three years of breathing room. Venture tracks Venture Investment Management Corp. (VIMAC...
...Ono. Based in Montreal, Pharand will focus on cross-border investments between Canada and the U.S. VIMAC's...

...million. Pharand joins from Innovatech Grand Montreal, where he was VP of life science investments. VIMAC's...